Track every registration update on the InsiderAlpha IPO tracker.
Updated Jul 16, 2026 · Last SEC filing 2026-06-26
Akari Therapeutics Plc (AKTX) has filed 2 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-26. 3 Form 8-K material event filings were reported by AKTX in the last 90 days. InsiderAlpha tracks every AKTX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001541157 |
|---|
| Form 4 filings (90d) | 2 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Latest Form 4 filing | 2026-06-26 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Farag Kameel D. | Interim CFO | A — Grant or award | 1.4K | $9.32 | $13K | SEC | |
| Farag Kameel D. | Interim CFO | A — Grant or award | 7.4K | $3.74 | $28K | SEC | |
| Farag Kameel D. | Interim CFO | A — Grant or award | 3.7K | $3.49 | $13K | SEC | |
| Farag Kameel D. | Interim CFO | A — Grant or award | 2.5K | $5.12 | $13K | SEC | |
| Farag Kameel D. | Interim CFO | A — Grant or award | 1.6K | $8.28 | $13K | SEC | |
| Farag Kameel D. | Interim CFO | A — Grant or award | 1.2K | $10.02 | $13K | SEC | |
| Farag Kameel D. | Interim CFO | A — Grant or award | 1.0K | $13.00 | $13K | SEC | |
| Farag Kameel D. | Interim CFO | A — Grant or award | 32.0K | $0.75 | $24K | SEC | |
| Farag Kameel D. | Interim CFO | A — Grant or award | 26.6K | $0.75 | $20K | SEC | |
| Farag Kameel D. | Interim CFO | A — Grant or award | 6.3K | $0.74 | $5K | SEC | |
| Gaslightwala Abizer | CEO | P — Open-market purchase | 3.0K | $0.90 | $3K | SEC | |
| Gaslightwala Abizer | CEO | P — Open-market purchase | 8.0K | $0.93 | $7K | SEC | |
| Gaslightwala Abizer | CEO | P — Open-market purchase | 10.0K | $0.94 | $9K | SEC | |
| Patel Samir Rashmikant | Insider | A — Grant or award | 400.0K | $0.00 | $200 | SEC | |
| Gaslightwala Abizer | Insider | A — Grant or award | 40.00M | $0.00 | $20K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Akari Therapeutics Plc (AKTX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Farag Kameel D. | 7 | $105K |
| Gaslightwala Abizer | 2 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in AKTX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live AKTX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.